Filing Details
- Accession Number:
- 0000899243-18-028347
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-06 19:30:55
- Reporting Period:
- 2018-10-31
- Accepted Time:
- 2018-11-06 19:30:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654909 | Jake Bauer | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-31 | 272 | $42.16 | 60,878 | No | 4 | A | Direct | |
Common Stock | Disposition | 2018-11-02 | 978 | $55.45 | 59,900 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.
- This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.